Dermata Therapeutics, Inc.
DRMA$2M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSAN DIEGO8 employees
Drugs in Pipeline
3
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
DRMA News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
DMT310
Acne Vulgaris
DMT210 Topical Gel 5%
Acne Rosacea
DMT210 Topical Gel
Atopic Dermatitis
| Drug Name | Phase | Indication | Designations |
|---|---|---|---|
DMT310 | Phase 3 | Acne Vulgaris | - |
DMT210 Topical Gel 5% | Phase 2 | Acne Rosacea | - |
DMT210 Topical Gel | Phase 2 | Atopic Dermatitis | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply